Armata Pharmaceuticals (ARMP) Return on Sales (2013 - 2020)

Armata Pharmaceuticals has disclosed Return on Sales across 6 years of filings, most recently posting 1.52% for Q2 2020.

• Return on Sales for Q2 2020 came in at 1.52%, changed N/A year-over-year; the trailing twelve-month figure through Jun 2020 was 1.82% (changed N/A YoY), and the FY2017 annual result was 0.49%, down 27.0% from the prior year.
• Return on Sales came in at 1.52% for Q2 2020 at Armata Pharmaceuticals, down from 2.43% in the prior quarter.
• In the past five years, Return on Sales ranged from a high of 2.43% in Q4 2017 to a low of 2.31% in Q2 2017.
• The 3-year median for Return on Sales is 0.43% (2016), against an average of 0.34%.
• Across the five-year window, Return on Sales soared 158 bps in 2016 and plunged 193 bps in 2017, its largest moves.
• Armata Pharmaceuticals' Return on Sales stood at 1.35% in 2016, then soared by 79 bps to 2.43% in 2017, then plunged by 163 bps to 1.52% in 2020.
• The last three Return on Sales figures came in at 1.52% (Q2 2020), 2.43% (Q4 2017), and 0.2% (Q3 2017), per Business Quant data.